Precipio Retained Earnings (Accumulated Deficit) 2010-2024 | PRPO
Precipio retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Precipio Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-102 |
| 2023 | $-98 |
| 2022 | $-92 |
| 2021 | $-80 |
| 2020 | $-72 |
| 2019 | $-61 |
| 2018 | $-48 |
| 2017 | $-32 |
| 2016 | $-11 |
| 2015 | $-213 |
| 2014 | $-184 |
| 2013 | $-169 |
| 2012 | $-152 |
| 2011 | $-143 |
| 2010 | $-133 |
| 2009 | $-130 |
| Precipio Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-102 |
| 2024-09-30 | $-102 |
| 2024-06-30 | $-101 |
| 2024-03-31 | $-100 |
| 2023-12-31 | $-98 |
| 2023-09-30 | $-99 |
| 2023-06-30 | $-98 |
| 2023-03-31 | $-95 |
| 2022-12-31 | $-92 |
| 2022-09-30 | $-90 |
| 2022-06-30 | $-87 |
| 2022-03-31 | $-85 |
| 2021-12-31 | $-80 |
| 2021-09-30 | $-78 |
| 2021-06-30 | $-76 |
| 2021-03-31 | $-73 |
| 2020-12-31 | $-72 |
| 2020-09-30 | $-70 |
| 2020-06-30 | $-66 |
| 2020-03-31 | $-64 |
| 2019-12-31 | $-61 |
| 2019-09-30 | $-57 |
| 2019-06-30 | $-55 |
| 2019-03-31 | $-49 |
| 2018-12-31 | $-48 |
| 2018-09-30 | $-41 |
| 2018-06-30 | $-37 |
| 2018-03-31 | $-34 |
| 2017-12-31 | $-32 |
| 2017-09-30 | $-22 |
| 2017-06-30 | $-15 |
| 2017-03-31 | $-227 |
| 2016-12-31 | $-11 |
| 2016-09-30 | $-220 |
| 2016-06-30 | $-218 |
| 2016-03-31 | $-217 |
| 2015-12-31 | $-213 |
| 2015-09-30 | $-194 |
| 2015-06-30 | $-187 |
| 2015-03-31 | $-187 |
| 2014-12-31 | $-184 |
| 2014-09-30 | $-177 |
| 2014-06-30 | $-177 |
| 2014-03-31 | $-173 |
| 2013-12-31 | $-169 |
| 2013-09-30 | $-164 |
| 2013-06-30 | $-159 |
| 2013-03-31 | $-156 |
| 2012-12-31 | $-152 |
| 2012-09-30 | $-149 |
| 2012-06-30 | $-146 |
| 2012-03-31 | $-146 |
| 2011-12-31 | $-143 |
| 2011-09-30 | $-144 |
| 2011-06-30 | $-143 |
| 2011-03-31 | $-136 |
| 2010-12-31 | $-133 |
| 2010-09-30 | $-133 |
| 2010-06-30 | $-132 |
| 2010-03-31 | $-131 |
| 2009-12-31 | $-130 |
| 2009-09-30 | $-130 |
| 2009-06-30 | $-130 |
| 2009-03-31 | $-129 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.009B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Enovis (ENOV) | United States | $1.825B | 11.29 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |